Article info
Clinical and epidemiological research
Extended report
Towards personalised treatment in primary Sjögren's syndrome: baseline parotid histopathology predicts responsiveness to rituximab treatment
- Correspondence to Dr Konstantina Delli, Department of Oral and Maxillofacial Surgery, University Medical Center Groningen, Hanzeplein 1, Groningen 9713 GZ, The Netherlands; k.delli{at}umcg.nl
Citation
Towards personalised treatment in primary Sjögren's syndrome: baseline parotid histopathology predicts responsiveness to rituximab treatment
Publication history
- Received July 25, 2015
- Revised December 2, 2015
- Accepted December 20, 2015
- First published January 12, 2016.
Online issue publication
October 31, 2019
Article Versions
- Previous version (31 October 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/